Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2012-05-08 BURRIS MICHELLE CFO Grant or award · Stock Option (right to buy) +15,000 15,000
2012-05-08 BURRIS MICHELLE CFO Grant or award · Restricted Stock Units +7,500 7,500
2012-05-08 BURRIS MICHELLE CFO Grant or award · Restricted Stock Units +17,500 17,500
2011-01-03 BURRIS MICHELLE CFO Grant or award · Stock Option +35,000 35,000
2010-06-08 BURRIS MICHELLE Director Grant or award · stock option (right to buy) +3,500 3,500
2009-05-12 BURRIS MICHELLE Director Grant or award · stock option (right to buy) +8,260 $7.25 $60K 8,260
2008-10-28 BURRIS MICHELLE Director Grant or award · stock option (right to buy) +17,000 $2.69 $46K 17,000
2007-05-10 BURRIS MICHELLE Director Grant or award · Non-qualified stock option (right to buy) +17,000 17,000
2006-05-09 BURRIS MICHELLE Director Grant or award · Non-qualified stock option (right to buy) +17,000 17,000
2005-05-23 BURRIS MICHELLE Director Grant or award · Non-qualified stock option (right to buy) +10,000 10,000
2004-05-05 BURRIS MICHELLE Director Grant or award · Non-qualified stock option (right to buy) +15,000 15,000

Page 1 of 1 · 11 trades